Intellia Therapeutics, Inc. (NTLA)

NASDAQ: NTLA · Real-Time Price · USD

17.56

+0.32 (1.86%)

At close: Jul 2, 2026, 4:00 PM EDT

17.60

+0.04 (0.23%)

After-hours: Jul 2, 2026, 7:57 PM EDT

Intellia Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 2, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	2,454	1,046	1,190	2,835	3,039	8,807
Market Cap Growth	147.26%	-12.10%	-58.04%	-6.70%	-65.49%	144.43%
Enterprise Value	2,017	689.14	798.35	2,039	1,977	8,133
Last Close Price	17.56	8.99	11.66	30.49	34.89	118.24
PS Ratio	37.12	15.45	20.56	78.17	58.31	266.46
PB Ratio	3.41	1.56	1.36	2.70	2.46	8.47
P/TBV Ratio	3.17	1.45	1.32	2.58	2.17	8.06
EV/Sales Ratio	30.51	10.18	13.79	56.20	37.93	246.05
Debt / Equity Ratio	0.10	0.10	0.22	0.09	0.09	0.06
Net Debt / Equity Ratio	-0.48	-0.53	-0.45	-0.76	-0.86	-0.65
Net Debt / EBITDA Ratio	0.72	0.83	0.75	1.57	2.36	2.59
Net Debt / FCF Ratio	0.81	0.90	1.10	1.95	3.06	2.84
Asset Turnover	0.08	0.07	0.05	0.03	0.04	0.03
Quick Ratio	5.04	4.42	5.50	8.23	9.45	5.97
Current Ratio	6.10	5.08	5.77	8.67	9.61	6.11
Return on Equity (ROE)	-61.07%	-53.48%	-54.00%	-42.10%	-41.67%	-34.18%
Return on Assets (ROA)	-52.56%	-43.38%	-42.88%	-36.53%	-32.56%	-27.18%
Return on Invested Capital (ROIC)	-131.42%	-110.87%	-145.59%	-241.38%	-169.93%	-160.11%
Return on Capital Employed (ROCE)	-59.23%	-48.50%	-47.16%	-39.96%	-35.76%	-30.08%
Buyback Yield / Dilution	-11.18%	-9.64%	-11.35%	-15.33%	-8.57%	-26.63%
Total Shareholder Return	-11.18%	-9.64%	-11.35%	-15.33%	-8.57%	-26.63%

SEC Filings: 10-K · 10-Q